CONNEXIN 40 TISSUE SPECIFIC GENE MUTATIONS
    1.
    发明申请
    CONNEXIN 40 TISSUE SPECIFIC GENE MUTATIONS 审中-公开
    CONNEXIN 40组织特异性基因突变

    公开(公告)号:US20090054248A1

    公开(公告)日:2009-02-26

    申请号:US11587867

    申请日:2005-04-28

    摘要: A method of detecting cardiac arrhythmia in a patient is described. This method involves determining whether there is a mutation in the nucleotide sequence, the amino acid sequence, or both, of connexin40 obtained from a patient. The mutation may be localized within the transmembrane domain of connexin40. Furthermore, there is described a method of identifying a compound for the treatment of cardiac arrhythmia. This method involves providing a cell culture that is characterized by having impaired intracellular trafficking, impaired electrical coupling, reduced gap junction plaque formation, reduced intracellular coupling, or a combination thereof, when compared to a wild-type cell. A compound is added to the cell culture, and restoration of intracellular trafficking, electrical coupling, gap junction plaque formation, intracellular coupling, or a combination thereof, is monitored.

    摘要翻译: 描述了一种检测患者心律失常的方法。 该方法包括确定从患者获得的连接蛋白40的核苷酸序列,氨基酸序列或两者是否存在突变。 突变可能位于连接蛋白40的跨膜结构域内。 此外,描述了鉴定用于治疗心律失常的化合物的方法。 该方法涉及提供细胞培养物,其特征在于与野生型细胞相比,其具有受损的细胞内运输,受损的电耦合,减少的间隙连接斑块形成,减少的细胞内偶联或其组合。 将化合物加入到细胞培养物中,监测细胞内运输,电耦合,间隙连接斑块形成,细胞内偶联或其组合的恢复。